These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 21277723

  • 1. Evaluation of diethylenetriaminepentaacetic acid-manganese(II) complexes modified by narrow molecular weight distribution of chitosan oligosaccharides as potential magnetic resonance imaging contrast agents.
    Huang Y, Zhang X, Zhang Q, Dai X, Wu J.
    Magn Reson Imaging; 2011 May; 29(4):554-60. PubMed ID: 21277723
    [Abstract] [Full Text] [Related]

  • 2. Gd complexes of diethylenetriaminepentaacetic acid conjugates of low-molecular-weight chitosan oligosaccharide as a new liver-specific MRI contrast agent.
    Huang Y, Cao B, Yang X, Zhang Q, Han X, Guo Z.
    Magn Reson Imaging; 2013 May; 31(4):604-9. PubMed ID: 23102519
    [Abstract] [Full Text] [Related]

  • 3. Chitosan oligosaccharide based Gd-DTPA complex as a potential bimodal magnetic resonance imaging contrast agent.
    Huang Y, Cao J, Zhang Q, Lu ZR, Hua MQ, Zhang XY, Gao H.
    Magn Reson Imaging; 2016 Jan; 34(1):1-7. PubMed ID: 26485295
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
    Cheng JJ, Zhu J, Liu XS, He DN, Xu JR, Wu LM, Zhou J, Feng Q.
    Acta Radiol; 2012 Oct 01; 53(8):900-7. PubMed ID: 22919051
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X, Jackson EF, Price RE, Kim EE, Wu Q, Wallace S, Charnsangavej C, Gelovani JG, Li C.
    Bioconjug Chem; 2004 Oct 01; 15(6):1408-15. PubMed ID: 15546209
    [Abstract] [Full Text] [Related]

  • 9. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging.
    Huang Y, Boamah PO, Gong J, Zhang Q, Hua M, Ye Y.
    Carbohydr Polym; 2016 Jun 05; 143():288-95. PubMed ID: 27083371
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relaxometric evaluation of novel manganese(II) complexes for application as contrast agents in magnetic resonance imaging.
    Aime S, Anelli L, Botta M, Brocchetta M, Canton S, Fedeli F, Gianolio E, Terreno E.
    J Biol Inorg Chem; 2002 Jan 05; 7(1-2):58-67. PubMed ID: 11862541
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and evaluation of Gd-DTPA-labeled arabinogalactans as potential MRI contrast agents.
    Li W, Li Z, Jing F, Deng Y, Wei L, Liao P, Yang X, Li X, Pei F, Wang X, Lei H.
    Carbohydr Res; 2008 Mar 17; 343(4):685-94. PubMed ID: 18258223
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Preclinical investigation of Mn(II)-diethylenetriaminepentaacetate (Mangapentetate) as paramagnetic contrast agent for magnetic resonance tomography].
    Usov VIu, Belianin ML, Karpova GV, Borodin OIu, Filimonov VD.
    Eksp Klin Farmakol; 2008 Mar 17; 71(4):41-6; discussion 47-8. PubMed ID: 18819440
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of a dendritic manganese-enhanced magnetic resonance imaging (MEMRI) contrast agent: synthesis, toxicity (in vitro) and relaxivity (in vitro, in vivo) studies.
    Bertin A, Steibel J, Michou-Gallani AI, Gallani JL, Felder-Flesch D.
    Bioconjug Chem; 2009 Apr 17; 20(4):760-7. PubMed ID: 19368343
    [Abstract] [Full Text] [Related]

  • 18. Investigation using an HER-2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drug.
    Sonoda A, Nitta N, Ohta S, Nitta-Seko A, Murata S, Jo J, Tabata Y, Takahashi M, Tani T, Murata K.
    J Magn Reson Imaging; 2009 Oct 17; 30(4):907-10. PubMed ID: 19787744
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging.
    Langereis S, de Lussanet QG, van Genderen MH, Meijer EW, Beets-Tan RG, Griffioen AW, van Engelshoven JM, Backes WH.
    NMR Biomed; 2006 Feb 17; 19(1):133-41. PubMed ID: 16450331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.